Literature DB >> 12269353

Effect of L-dopa on human muscle sympathetic nerve activity.

S Takeuchi1, Y Sugiyama, T Mano, S Iwase, T Matsukawa.   

Abstract

This study was undertaken to clarify the mechanism of orthostatic hypotension, one of the side effects frequently encountered after administration of levodopa (L-dopa). Muscle sympathetic nerve activity (MSNA) was measured concomitantly with blood pressure (BP), heart rate (HR) and calf blood flow (calf BF). The responses of these variables to head-up tilting (HUT) were analyzed before and after intravenous administration of L-dopa (50 mg) in eight healthy subjects. L-dopa induced significant increases in MSNA, with concomitant decreases in BP and no changes in calf BF in the supine position. At each angle of HUT, both MSNA and the calf BF increased, following administration of L-dopa. The pattern of MSNA changes was dissociated from that of the calf BF under the influence of L-dopa. These results suggest that peripheral, rather than central, mechanisms are involved in L-dopa-induced orthostatic hypotension.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 12269353

Source DB:  PubMed          Journal:  Environ Med        ISSN: 0287-0517


  3 in total

1.  Effects of subthalamic nucleus stimulation and levodopa on the autonomic nervous system in Parkinson's disease.

Authors:  Janne Ludwig; Piet Remien; Christoph Guballa; Andreas Binder; Sabine Binder; Jörn Schattschneider; Jan Herzog; Jens Volkmann; Günther Deuschl; Gunnar Wasner; Ralf Baron
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-19       Impact factor: 10.154

2.  Age and duration related changes in muscle sympathetic nerve activity in Parkinson's disease.

Authors:  K Shindo; H Watanabe; H Tanaka; K Ohashi; T Nagasaka; S Tsunoda; Z Shiozawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

Review 3.  The Human Experience with Intravenous Levodopa.

Authors:  Shan H Siddiqi; Natalia K Abraham; Christopher L Geiger; Morvarid Karimi; Joel S Perlmutter; Kevin J Black
Journal:  Front Pharmacol       Date:  2016-01-06       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.